Bangladesh vs Tunisia: Access to anti-retroviral drugs, female
Bangladesh
33.0%
in 2024
Tunisia
33.0%
in 2024
Bangladesh rank
133rd
Tunisia rank
133rd
Access to anti-retroviral drugs, female over time
- Bangladesh
- Tunisia
How they compare
Bangladesh currently reports 33.0% against 33.0% in Tunisia, a difference of 0.0%.
Across all 25 years both countries report, Tunisia has been ahead every year.
Bangladesh ranks 133rd and Tunisia ranks 133rd of 141 countries.
Tunisia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bangladesh | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.7% | 4.4% | 2.7% | Tunisia |
| 2010s | 16.0% | 19.9% | 3.9% | Tunisia |
| 2020s | 30.0% | 33.8% | 3.8% | Tunisia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Bangladesh or Tunisia?
- Bangladesh, at 33.0% against 33.0% in Tunisia as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Bangladesh and Tunisia?
- 0.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Tunisia?
- 25 years are reported by both, from 2000 to 2024.
- How do Bangladesh and Tunisia rank globally for access to anti-retroviral drugs, female?
- Bangladesh ranks 133rd and Tunisia ranks 133rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.